Cross-sectional study reveals high dry eye frequency in glaucoma patients, indicating age and medication effects.
Background: Dry eye disease (DED) is a multifactorial disease of the eye. The disease is characterised by failure to produce sufficiently high amounts of tears to moisturise the ocular surface. Objective: To determine the frequency and influencing factors of dry eye among glaucoma patients visiting the tertiary eye hospital of Karachi. Methodology: A cross-sectional study was commenced in the glaucoma department of Al-Ibrahim Eye Hospital (AIEH), Karachi, from July to December 2023. The sample was collected through non-probability consecutive sampling. Patients underwent detailed examination, including Intraocular pressure (IOP) and Dry eye assessment. Dry eye was categorised as Severe (0-5mm wetting), moderate (>5-10mm wetting), mild (>10-15mm wetting) and normal (>15mm wetting). The data was analysed using SPSS Version 26.0. Results: A total of 75 eyes of 58 patients were included in the study. Mean age was 52.13±6.68 years. The majority of the patients were males, 52% (n=30). The severity of dry eye was frequently seen in patients above 50 years of age, 47.5% (n=19). In multivariable regression analysis, patients with an age above 50 years have high chances of dry eye compared to those aged 16 to 30 years (aOR: 1.509, 95% CI: 0.725–2.961). Among different medications, the combination of an anhydrase inhibitor and a beta blocker has a 2.131 times higher risk of dry eyes compared to prostaglandin (aOR: 2.131, 95% CI: 0.336–8.445). Conclusion: The Study concludes that the age, duration of glaucoma and combination of different glaucoma medications are independently associated with the occurrence of dry eye.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: